Myths vs facts: Pharmakogenetik Medicheck and gut health

The question of myths vs facts regarding pharmacogenetics (Medicheck) and gut health cannot be directly answered from the provided context. The context covers general DNA tests (e.g., MTHFR, ACTN3, CLOCK) and microbiome analyses, but not pharmacogenetics in the narrow sense—i.e., how genetic variants affect drug metabolism. Fact: Pharmacogenetic testing is clinically relevant for certain drugs (e.g., clopidogrel, tamoxifen, some antidepressants). A link to gut health exists indirectly via the gut microbiome, which can metabolize medications (pharmacomicrobiomics). However, evidence for combined gene–gut personalized recommendations is still weak. Marketing often overpromises. A standalone 'Medicheck' without medical interpretation can lead to misinterpretation. Conclusion: Pharmacogenetics has proven utility in specific drug contexts, but combining it with gut health is largely exploratory. Always consult a physician or pharmacist before changing medication based on such tests.